• Wed news: Novo and Viking heat up MASH space. New Pfizer R&D chief. Trump and the Biosecure Act. Sage Huntington’s prospect flunks trial. Dr. Oz to run CMS. See more on our front page

Pipeline

















Stronger pipeline products are all partnered. Company has been around for over 40 years and never commercialized anything on their own. Anything they are commercializing had trouble finding a partner.
 








Yes they have a new field team they are anticipating hiring leaders starting Q1 and sales team Q2 2025.
They are preparing to move into a crowded market with no advantage over the current therapies. Ionis has always partnered their products and not built commercially. There is a reason this one has no partner.